AGP Executive Report
Last update: 10 hours agoCare Costs: A Federal Reserve report found 24% of insured U.S. adults skipped medical care because of cost in 2025; 9% went without prescription medicine. Drug Approval: The FDA granted accelerated approval to Ultomiris for adults with primary immunoglobulin A nephropathy, based on reduced proteinuria; continued approval depends on confirmation of clinical benefit. Disaster Preparedness: A study of older adults reliant on electricity-powered medical devices found no immediate surge in hospitalizations or deaths after two hurricanes, but Hurricane Matthew was followed by sustained increases over the next year. Coverage Changes: Minnesota officials estimate 392,000 Medicare Advantage members will lose their current plan for 2027, urging enrollees to review alternatives during open enrollment. Rural Care: A community cooperative secured financing to reopen Chippewa Falls’ former St. Joseph’s Hospital as a full-service facility by August 2027, after regional hospital closures left tens of thousands without consistent local care. Drug Accountability: Gilead will pay Texas $45 million to resolve claims that incentives improperly influenced prescriptions billed to Medicaid; the company’s settlement does not establish wrongdoing. Global Health: WHO support helped restore beds, ambulances and essential equipment at a hospital in Ebola-hit Ituri, Congo, where the outbreak had disrupted maternity and other care.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.